FTC sues main pharmacy reward professionals over insulin price ranges The company brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of life-conserving insulin drugs. Insurers will go on vertically integrating to help keep additional income in-residence, and https://arizona-hard-nutrition-fa19854.fireblogz.com/61937474/considerations-to-know-about-healthcare-news